HUMAN PAPILLOMA VIRUS

This study is testing whether young adults aged 15-26 need two or three doses of the HPV vaccine for protection. Researchers are comparing the standard three-dose schedule against a two-dose schedule with a delayed third dose. They're measuring immune responses in 767 participant…

This study is testing whether using lower doses of radiation to a smaller area of the head and neck can still effectively control cancer after surgery for HPV-positive throat cancer. The goal is to see if this 'de-intensified' approach can maintain good cancer control while poten…

This study is testing a new, low-cost HPV screening test called ScreenFire that women can use at home. It aims to see if this self-collected test works as well as the standard test done by a healthcare provider for detecting early signs of cervical cancer. The study involves 9,10…

This study is testing whether a single dose of the HPV vaccine can prevent new HPV infections in women who are living with HIV and have already received HPV vaccination in the past. Researchers are comparing giving the HPV vaccine immediately versus after an 18-month delay in 778…

This study is testing whether giving clinics financial bonuses can help doctors communicate better and get more children vaccinated against HPV. It involves 34 clinics in North Carolina, where some clinics get communication training and others get the same training plus a bonus p…

This study is testing whether giving girls just one or two doses of the HPV vaccine works as well as the standard three doses to prevent cervical cancer. It involves 930 girls aged 9-14 in Tanzania and will compare their immune responses over several years. The goal is to find a …

This study aims to understand why some oral HPV infections last a long time and may lead to throat cancer. Researchers are screening 1,500 adults, then following those with signs of the virus for several years to track their health. The goal is to learn which factors put people a…